1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin has been researched along with Hypotension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, GK; DiMartino, MJ; Gabel, RA; Hanna, N; Macia, RA; Silver, AC | 1 |
| Brooks, VL; Hatton, DC | 1 |
2 other study(ies) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and Hypotension
| Article | Year |
|---|---|
Hypotension induced by vasopressin antagonists in rats: role of mast cell degranulation.
Topics: Animals; Arginine Vasopressin; Cell Degranulation; Edema; Hindlimb; Histamine Release; Hypotension; Male; Mast Cells; Rats; Rats, Inbred Strains; Time Factors; Vasopressins | 1990 |
Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Deamino Arginine Vasopressin; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Rate; Hypotension; Injections, Intravenous; Male; Nitroprusside; Norepinephrine; Receptors, Angiotensin; Receptors, Vasopressin; Sympathetic Nervous System; Vascular Resistance; Vasopressins | 1991 |